Primary Insider Notification

15. Jun 2018 | 1 min read

Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Bård Sundrehagen is 307,010 shares.

 

MeldingsID: 453767
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja

Vedlegg: Primary insider notification Baard Sundrehagen (4)

You may also read


Jul 02, 2026 - Ole Sørlie

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

Jun 24, 2026 - Ole Sørlie

ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

May 29, 2026 - Ole Sørlie

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..